Publications by authors named "P Boraschi"
Article Synopsis
- - Both Magnetic Resonance Enterography (MRE) and Computed Tomography Enterography (CTE) are important imaging techniques used for diagnosing and treating inflammatory bowel disease (IBD), with CTE being favored in urgent situations like suspected complications.
- - CTE provides rapid and precise imaging but involves exposure to ionizing radiation, while MRE avoids radiation and excels in evaluating the small intestine and perianal disease, making it ideal for patients requiring frequent monitoring or those who are pregnant.
- - The review highlights the strengths and weaknesses of both imaging methods, aiming to inform about their technical aspects, benefits, limitations, and the specific findings they can reveal regarding IBD.
Purpose: To compare the adherence of the interpretation and reporting staging system, respectively proposed in the 2012 and 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guidelines for Magnetic Resonance Imaging (MRI) staging of rectal cancer, focusing on the improvement offered by the criteria introduced by 2016 ESGAR guidelines.
Method: Fifty-six patients affected by rectal cancer were included; 25/56 patients underwent upfront surgery; 31 underwent to neo-adjuvant chemo-radiotherapy before surgery. All patients underwent 3 T MRI examination for local staging.
Purpose: To analyze the role of qualitative and quantitative 3 T MR imaging assessment as a non-invasive method for the evaluation of disease severity in patients with primary sclerosing cholangitis (PSC).
Methods: A series of 26 patients, with histological diagnosis of PSC undergoing 3 T MRI and hepatological evaluation, was retrospectively enrolled. All MR examinations included diffusion-weighted imaging (DWI), T2-weighted (T2w) and T1-weighted (T1w) sequences, before and after administration of Gd-EOB-DTPA with the acquisition of both dynamic and hepato-biliary phase (HBP).
Background: Advances in surgical techniques and systemic treatments have increased the likelihood of achieving radical surgery and long-term survival in metastatic colorectal cancer (mCRC) patients with initially unresectable colorectal liver metastases (CRLMs). Nonetheless, roughly half of the patients resected after an upfront systemic therapy experience disease relapse within 6 months from surgery, thus leading to the question whether surgery is actually beneficial for these patients.
Materials And Methods: A real-world dataset of mCRC patients with initially unresectable liver-limited disease treated with conversion chemotherapy followed by radical resection of CRLMs at three high-volume Italian institutions was retrospectively assessed with the aim of investigating the association of baseline and pre-surgical clinical, radiological and molecular factors with the risk of relapse within 6 or 12 months from surgery.
Article Synopsis
- * Cross-sectional imaging, especially contrast-enhanced CT scans, helps doctors find issues early and accurately.
- * MRI is also useful but usually for later problems or specific areas, and doctors need to communicate well to create the best treatment plans for patients.